These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 3053124)

  • 1. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical indications and efficacy of colloidal bismuth subcitrate.
    Lambert JR
    Scand J Gastroenterol Suppl; 1991; 185():13-21. PubMed ID: 1957121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal bismuth subcitrate in peptic ulcer--a review.
    Tytgat GN
    Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
    Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
    Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bismuth: effects on gastritis and peptic ulcer.
    Rokkas T; Sladen GE
    Scand J Gastroenterol Suppl; 1988; 142():82-6. PubMed ID: 3047853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the modes of action of colloidal bismuth subcitrate.
    Hall DW
    Scand J Gastroenterol Suppl; 1989; 157():3-6; discussion 21-2. PubMed ID: 2665050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers].
    Hu FL; Jia BQ; Gao HZ
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):339-41, 382. PubMed ID: 2269032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).
    Wieriks J; Hespe W; Jaitly KD; Koekkoek PH; Lavy U
    Scand J Gastroenterol Suppl; 1982; 80():11-6. PubMed ID: 6962539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN
    S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety profile of De-Nol.
    Bader JP
    Digestion; 1987; 37 Suppl 2():53-9. PubMed ID: 3622947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.
    Lee SP
    Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth is better.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1988; 155():16-7. PubMed ID: 3244996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
    Barbara L; Corinaldesi R; Rea E; Paternicò A; Stanghellini V
    Scand J Gastroenterol Suppl; 1986; 122():30-4. PubMed ID: 3535019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.